» Articles » PMID: 38425435

Gene Regulation and Mitochondrial Activity During White and Brown Adipogenesis Are Modulated by KDM5 Histone Demethylase

Overview
Journal J Endocr Soc
Specialty Endocrinology
Date 2024 Mar 1
PMID 38425435
Authors
Affiliations
Soon will be listed here.
Abstract

Body fat accumulation differs between males and females and is influenced by both gonadal sex (ovaries vs testes) and chromosomal sex (XX vs XY). We previously showed that an X chromosome gene, , is expressed at higher levels in females compared to males and correlates with adiposity in mice and humans. encodes a KDM5 histone demethylase that regulates gene expression by modulating histone methylation at gene promoters and enhancers. Here, we use chemical inhibition and genetic knockdown to identify a role for KDM5 activity during early stages of white and brown preadipocyte differentiation, with specific effects on white adipocyte clonal expansion, and white and brown adipocyte gene expression and mitochondrial activity. In white adipogenesis, KDM5 activity modulates H3K4 histone methylation at the gene promoter to repress gene expression and promote progression from preadipocytes to mature adipocytes. In brown adipogenesis, KDM5 activity modulates H3K4 methylation and gene expression of , which is required for thermogenesis. Unbiased transcriptome analysis revealed that KDM5 activity regulates genes associated with cell cycle regulation and mitochondrial function, and this was confirmed by functional analyses of cell proliferation and cellular bioenergetics. Using genetic knockdown, we demonstrate that KDM5C is the likely KDM5 family member that is responsible for regulation of white and brown preadipocyte programming. Given that KDM5C levels are higher in females compared to males, our findings suggest that sex differences in white and brown preadipocyte gene regulation may contribute to sex differences in adipose tissue function.

References
1.
Wiese C, Avetisyan R, Reue K . The impact of chromosomal sex on cardiometabolic health and disease. Trends Endocrinol Metab. 2023; 34(10):652-665. PMC: 11090013. DOI: 10.1016/j.tem.2023.07.003. View

2.
Collins S, Yehuda-Shnaidman E, Wang H . Positive and negative control of Ucp1 gene transcription and the role of β-adrenergic signaling networks. Int J Obes (Lond). 2010; 34 Suppl 1:S28-33. DOI: 10.1038/ijo.2010.180. View

3.
Mikkelsen T, Ku M, Jaffe D, Issac B, Lieberman E, Giannoukos G . Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007; 448(7153):553-60. PMC: 2921165. DOI: 10.1038/nature06008. View

4.
Outchkourov N, Muino J, Kaufmann K, van IJcken W, Groot Koerkamp M, van Leenen D . Balancing of histone H3K4 methylation states by the Kdm5c/SMCX histone demethylase modulates promoter and enhancer function. Cell Rep. 2013; 3(4):1071-9. DOI: 10.1016/j.celrep.2013.02.030. View

5.
Nappi R, Chedraui P, Lambrinoudaki I, Simoncini T . Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022; 10(6):442-456. DOI: 10.1016/S2213-8587(22)00076-6. View